Companies /Industrials

Crane Company

NYSE: CR Specialty Industrial Machinery
$204.03
▲ $0.27 (+0.13%) today
Markets closed · 4:56pm ET

24/7 Wall St. View

CR at a Glance

Valuation
Market cap
$11.8B
P/E ratio
35.7
Dividend yield
0.47%
Profitability
Revenue (TTM)
$2.6B
Profit margin
13.0%
EPS (TTM)
$5.71
Price
52-week range
$159 – $230
24/7 target
$243.23
Street target
$237.20
Earnings
Next report
Oct 27, 2026

Headquartered in Stamford, CT Fiscal year ends December NYSE: CR craneco.com

About Crane

Crane Company is a manufacturer of highly engineered components for mission-critical applications across the aerospace, defense, space, and process industry end markets. Founded in 1855, the company operates through two strategic growth platforms: Aerospace & Advanced Technologies (AAT), which serves aerospace, defense, and space customers with precision-engineered components, and Process Flow Technologies (PFT), which provides flow control solutions and sensing technologies for process industries. The company has approximately 8,300 employees across the Americas, Europe, the Middle East, Asia, and Australia. Crane has recently expanded its portfolio through four acquisitions — Druck (pressure sensing), Panametrics (flow measurement), Reuter-Stokes (radiation detection), and optek-Danulat (process analytics) — which collectively contributed nearly 20% of quarterly sales growth. The company trades on the NYSE under the ticker CR. Updated

CR Coverage

10:45am ET
Industrials

Is It a Good Idea for Circor to Reject Crane’s Bid?

Circor shares were crushed on Monday after it came out that the firm’s board of directors had unanimously rejected a buyout bid. Specifically, this was a revised acquisition bid from Crane.

CR
Chris Lange

Frequently Asked Questions

What does Crane do?

Crane Company is a manufacturer of highly engineered components for mission-critical applications across the aerospace, defense, space, and process industry end markets.

What is the CR stock price target?

24/7 Wall St.'s 12-month price target for CR is $243.23, rated Buy. The Wall Street consensus target is $237.20. CR price prediction →